INM icon

InMed Pharmaceuticals
INM

9 hedge funds and large institutions have $665K invested in InMed Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$530K
2
+$86.5K
3
+$49.1K
4
Renaissance Technologies
Renaissance Technologies
New York
+$40.5K
5
TDC
Thompson Davis & Co
Virginia
+$24.7K

Top Sellers

1
-$25.2K
2
-$1.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$482K
DS
2
DRW Securities
Illinois
$78.5K
VF
3
Virtu Financial
New York
$45K
Renaissance Technologies
4
Renaissance Technologies
New York
$36.8K
TDC
5
Thompson Davis & Co
Virginia
$22.4K
SS
6
SBI Securities
Japan
$657
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4
AWM
8
AllSquare Wealth Management
New York
$2
UBS Group
9
UBS Group
Switzerland
–
TRCT
10
Tower Research Capital (TRC)
New York
–